Trials / Active Not Recruiting
Active Not RecruitingNCT04433234
Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
A Phase II, Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Daiichi Sankyo Co., Ltd. · Industry
- Sex
- Male
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-5141b | Administered via subcutaneous injection once weekly |
Timeline
- Start date
- 2020-06-30
- Primary completion
- 2027-01-31
- Completion
- 2027-01-31
- First posted
- 2020-06-16
- Last updated
- 2025-09-19
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04433234. Inclusion in this directory is not an endorsement.